MeSH term
Frequency | Condition_Probility | Female | 14 | 0.0 |
Humans | 121 | 0.0 |
Acute Disease | 3 | 0.0 |
Adult | 5 | 0.0 |
Comparative Study | 18 | 0.0 |
Cell Line, Transformed | 3 | 0.0 |
DNA Repair | 3 | 0.0 |
Models, Genetic | 3 | 0.0 |
Phosphorylation | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 90 | 0.0 |
Telomeric Repeat Binding Protein 2/*metabolism | 2 | 40.0 |
*Promoter Regions (Genetics) | 7 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 47 | 0.0 |
Gene Expression Profiling | 4 | 0.0 |
Multigene Family | 2 | 0.0 |
Nucleic Acid Hybridization | 6 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
Oncogenes | 5 | 2.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Chromosome Mapping | 10 | 0.0 |
Down-Regulation | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 4 | 0.0 |
Neoplasm Transplantation | 2 | 0.0 |
*Oligonucleotide Array Sequence Analysis | 2 | 1.0 |
Oncogenes/*genetics | 2 | 2.0 |
Tumor Cells, Cultured | 22 | 0.0 |
Up-Regulation | 2 | 0.0 |
Amino Acid Sequence | 33 | 0.0 |
Molecular Sequence Data | 59 | 0.0 |
Protein Binding | 11 | 0.0 |
Protein Structure, Tertiary | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Animals | 56 | 0.0 |
Base Sequence | 44 | 0.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
DNA/metabolism | 8 | 0.0 |
Rats/*genetics | 2 | 3.0 |
Sequence Homology, Nucleic Acid | 13 | 0.0 |
Amino Acid Motifs | 4 | 0.0 |
Binding Sites | 27 | 0.0 |
DNA/*metabolism | 5 | 1.0 |
DNA-Binding Proteins/chemistry/metabolism | 2 | 5.0 |
Magnetic Resonance Spectroscopy | 5 | 0.0 |
Models, Molecular | 6 | 0.0 |
Protein Conformation | 5 | 0.0 |
Sequence Homology, Amino Acid | 11 | 0.0 |
3T3 Cells | 3 | 0.0 |
*Cell Cycle Proteins | 5 | 0.0 |
*DNA-Binding Proteins | 5 | 0.0 |
Mice | 19 | 0.0 |
Promoter Regions (Genetics) | 9 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 7 | 0.0 |
*Trans-Activation (Genetics) | 8 | 1.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Kinetics | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Conserved Sequence | 6 | 0.0 |
DNA-Binding Proteins/metabolism | 4 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Rats | 6 | 0.0 |
TATA Box | 2 | 0.0 |
Transcription Factors/metabolism | 5 | 0.0 |
Transfection | 10 | 0.0 |
Chromosomes, Human, Pair 6/*genetics | 2 | 1.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase | 3 | 4.0 |
Deoxyribonuclease IV (Phage T4-Induced) | 3 | 6.0 |
Retroviridae/genetics | 2 | 0.0 |
Cell Transformation, Neoplastic/*genetics | 2 | 1.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Blotting, Northern | 6 | 0.0 |
Gene Amplification | 2 | 0.0 |
Genes, myb/*genetics | 3 | 60.0 |
DNA Primers | 4 | 0.0 |
Flow Cytometry | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Cell Line | 21 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics | 2 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Proto-Oncogene Proteins c-myb/*metabolism | 3 | 37.0 |
*Transcription, Genetic | 9 | 0.0 |
Gene Expression Regulation | 16 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Trans-Activators/*metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
CCAAT-Enhancer-Binding Proteins | 3 | 1.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Proteins/*genetics | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Chickens | 5 | 0.0 |
Proto-Oncogene Proteins/*genetics | 14 | 1.0 |
*Repressor Proteins | 3 | 0.0 |
Retroviridae Proteins, Oncogenic/genetics | 2 | 14.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Oncogene Proteins v-myb | 9 | 56.0 |
*Oncogenes | 19 | 4.0 |
Proto-Oncogene Proteins c-myb | 35 | 56.0 |
Trans-Activators/*genetics | 3 | 0.0 |
Chromosomes, Human, Pair 6 | 4 | 2.0 |
Genetic Markers | 3 | 0.0 |
Restriction Mapping | 5 | 0.0 |
Retroviridae Proteins, Oncogenic/*genetics | 2 | 9.0 |
Cloning, Molecular | 17 | 0.0 |
Cells, Cultured | 5 | 0.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Cell Division | 8 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 3 | 0.0 |
Genes, myb/genetics | 2 | 66.0 |
Chromosome Mapping/*methods | 2 | 1.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Exons | 5 | 0.0 |
Gene Expression | 5 | 0.0 |
Quail | 3 | 7.0 |
Evolution | 2 | 0.0 |
Mutagenesis | 2 | 0.0 |
Temperature | 2 | 0.0 |
Transcription, Genetic | 15 | 0.0 |
COS Cells | 3 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Proto-Oncogene Proteins/*physiology | 5 | 2.0 |
Sequence Deletion | 2 | 0.0 |
Trans-Activation (Genetics) | 6 | 0.0 |
*Transcription Factors | 4 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 4 | 0.0 |
Proto-Oncogenes/*genetics | 3 | 4.0 |
RNA, Messenger/biosynthesis/genetics | 2 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Genes, Structural | 4 | 0.0 |
Nuclear Proteins/physiology | 2 | 2.0 |
Proto-Oncogene Proteins/physiology | 2 | 1.0 |
Transcription Factors/*physiology | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 5 | 0.0 |
Hela Cells | 10 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Male | 10 | 0.0 |
Blotting, Southern | 9 | 0.0 |
Blotting, Western | 2 | 0.0 |
Introns | 4 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Aged | 3 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Binding, Competitive | 3 | 0.0 |
Time Factors | 4 | 0.0 |
DNA Primers/chemistry | 3 | 0.0 |
*Hematopoiesis | 3 | 1.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
DNA | 3 | 0.0 |
Consensus Sequence | 3 | 0.0 |
*Genes, Structural | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Protein Kinases/genetics | 2 | 3.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Cell Differentiation/drug effects | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Retroviridae Proteins, Oncogenic/metabolism | 3 | 8.0 |
Alleles | 3 | 0.0 |
Mutation | 6 | 0.0 |
Oligonucleotide Probes | 2 | 0.0 |
Cell Differentiation | 4 | 0.0 |
RNA Splicing | 3 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Genomic Library | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Proto-Oncogene Protein c-kit | 2 | 2.0 |
*Proto-Oncogenes | 7 | 1.0 |
RNA, Messenger/genetics | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
DNA Probes | 6 | 0.0 |
*Genetic Markers | 3 | 0.0 |
Karyotyping | 4 | 0.0 |
Middle Aged | 4 | 0.0 |
Neoplasm Proteins/*biosynthesis | 2 | 2.0 |
Proto-Oncogene Proteins/*biosynthesis | 2 | 1.0 |
Nucleic Acid Conformation | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
DNA, Neoplasm/genetics/isolation & purification | 3 | 2.0 |
Immunoblotting | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
Interphase | 2 | 1.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
Chromosome Deletion | 4 | 0.0 |
*Genes, myc | 3 | 1.0 |
Proto-Oncogene Proteins/genetics/*metabolism | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
RNA, Antisense | 2 | 3.0 |
*Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
Bone Marrow/pathology | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 4 | 0.0 |
Proto-Oncogene Proteins c-myc/genetics/metabolism | 2 | 6.0 |
Oncogene Proteins/genetics | 2 | 2.0 |
Platelet-Derived Growth Factor/genetics | 2 | 6.0 |
Child | 2 | 0.0 |
Dactinomycin/pharmacology | 2 | 0.0 |
Protein-Tyrosine Kinase/genetics | 3 | 2.0 |
*Linkage (Genetics) | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
*Gene Amplification | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Mice, Nude | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
RNA, Neoplasm/analysis | 2 | 0.0 |
Genes, myb | 2 | 40.0 |
